New Treatment for Spine Injury
A potential benefit is being seen with an Australian-invented stem cell to be used in spine treatment. For the first time, it has been successfully done in the United States.
Looking into the technicalities, bone-marrow derived stem cells, mesenchymal precursor cells (MPCs), are used to enhance bone growth. This prevents back pain.
The results were announced at the JP Morgan Healthcare Conference in San Francisco. Here, phase-2 trials have been conducted.
There were 24 patients who were involved in the experiment. First group was given the standard treatment, second one received 25million MPCs and third one 75 million MPCs.
No serious adverse effects have been witnessed. In this experiment, it was seen that 25m MPC proved to create more bone fusion. This appears to be less complicated.
In this trial, Dr. Randall Dryer, an orthopedic surgeon at the Central Texas Institute in Austin, says that the chemicals involved, turn stem cells into bone forming cells.
The study has been carried out by The Food and Drug Administration (FDA), where they have compared stem cells with bones taken from hips of the patients (standard process). Hydroxyapatite and tricalcium phosphate are used in addition with stem cells to thrive bone growth.
If the tests prove positive till phase-3 for stem cells, then it will be seen as a success story for spine treatment.
United Kingdom News
- UK electric car adoption pace not quick enough to meet government targets: Study
- Honda, KTM, Piaggio & Yamaha set up swappable battery consortium
- ACC to receive €437 million to build battery gigafactory
- European plug-in car registrations jump 237% year-over-year in Q2 2021
- Zapp i300 e-scooter available in Germany, with price tag of €6,300